Brown University School of Public Health's Dr. Amy Nunn and Johns Hopkins Bloomberg School of Public Health colleague Dr. Lorraine Dean led research examining barriers to the HIV pre-exposure prophylaxis drug known as PrEP. Poor uptake of the drug can be attributed to stigma, limited awareness, and lack of accessibility to health care and health insurance.